L-arginine is unlikely to exert neuroendocrine effects in humans via the generation of nitric oxide.
There is now considerable evidence that nitric oxide is an important neuroregulatory agent, but there has been very little investigation of its possible role in neuroendocrine mechanisms in humans. We have investigated the effects of two nitric oxide precursors, L-arginine and molsidomine, under bas...
Main Authors: | Korbonits, M, Trainer, P, Fanciulli, G, Oliva, O, Pala, A, Dettori, A, Besser, M, Delitala, G, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1996
|
Similar Items
-
The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
by: Korbonits, M, et al.
Published: (1999) -
NITRIC-OXIDE AS A NOVEL REGULATOR OF NEUROENDOCRINE FUNCTION - CONTROL OF CORTICOTROPIN-RELEASING HORMONE-41 RELEASE FROM THE RAT HYPOTHALAMUS INVITRO
by: Costa, A, et al.
Published: (1992) -
Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.
by: Delitala, G, et al.
Published: (1994) -
Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
by: Korbonits, M, et al.
Published: (1995) -
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
by: Korbonits, M, et al.
Published: (1998)